first glp-1 The journey: from discovery science to therapeutic impact Generic Liraglutide Approved, Marking First

Ozempics active ingredient is semaglutide, which is a GLP-1 agonist, which can help people control blood glucose levels

In a 16-week study of 103 patients treated with clozapine or olanzapine, the GLP-1 agonist liraglutide was associated with an average weight reduction of 11.7 lb versus placebo, as well as improvements in glucose tolerance, blood pressure, cholesterol, and visceral fat (Larsen JR et al, JAMA Psychiatry 2017;74(7):719728)

Prospective randomized controlled trials are essential to confirm these findings and to further elucidate the risk-benefit profile of GLP-1 receptor agonists in this unique patient cohort

Controlled release of liraglutide using thermogelling polymers in treatment of diabetes

Who Can Benefit from GLP-1 Weight Loss Treatment

And now, NIA scientists are using part of that same venom to develop promising new treatments for Alzheimers disease, diabetes, and other diseases common to older age